Arkolith/Insider Trading/TCON/Form 4

Opaleye Management Inc.

10% OwnerTracon Pharmaceuticals, Inc. (TCON) · full profile →Form 4 · filed Dec 8, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2K
Net Open-Market Flow
-$2K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 6, 2022Option exercise(X)222K$0.01$2K4.0M
Dec 6, 2022Sell(S)2K$1.44$2K4.0M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 6, 2022Option exercise(X)222K$0.01$2K1.7M

Transaction Codes

X
Exercise of in-the-money derivative
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-22-034965) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML